What is the share price of Tarsons Products Ltd (TARSONS) today?
The share price of TARSONS as on 18th September 2026 is ₹306.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Tarsons Products Ltd (TARSONS) share?
The past returns of Tarsons Products Ltd (TARSONS) share are- Past 1 week: -2.05%
- Past 1 month: -14.46%
- Past 3 months: 13.78%
- Past 6 months: 61.70%
- Past 1 year: -2.95%
- Past 3 years: -42.71%
- Past 5 years: -62.84%
What are the peers or stocks similar to Tarsons Products Ltd (TARSONS)?
The peers or stocks similar to Tarsons Products Ltd (TARSONS) include:What is the market cap of Tarsons Products Ltd (TARSONS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tarsons Products Ltd (TARSONS) is ₹1637.69 Cr as of 18th September 2026.What is the 52 week high and low of Tarsons Products Ltd (TARSONS) share?
The 52-week high of Tarsons Products Ltd (TARSONS) is ₹375 and the 52-week low is ₹164.45.What is the PE and PB ratio of Tarsons Products Ltd (TARSONS) stock?
The P/E (price-to-earnings) ratio of Tarsons Products Ltd (TARSONS) is 114.44. The P/B (price-to-book) ratio is 2.58.Which sector does Tarsons Products Ltd (TARSONS) belong to?
Tarsons Products Ltd (TARSONS) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Tarsons Products Ltd (TARSONS) shares?
You can directly buy Tarsons Products Ltd (TARSONS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Tarsons Products Ltd
TARSONS Share Price
NSE₹306.100.15% (-0.45)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TARSONS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TARSONS Performance & Key Metrics
TARSONS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 147.94 | 2.58 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.79 | 5.87 | 0.48% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
TARSONS Company Profile
Tarsons Products Limited is engaged in the designing, development, manufacturing of a range of labware products which helps scientific discovery and healthcare
PE Ratio
40.20
40.20
1Y Return
11.04%
11.04%
Buy Reco %
77.78
77.78
POLYMED
PE Ratio
53.89
53.89
1Y Return
14.50%
14.50%
Buy Reco %
80.00
80.00
PE Ratio
88.91
88.91
1Y Return
22.78%
22.78%
FISCHER
PE Ratio
74.98
74.98
1Y Return
70.69%
70.69%
Buy Reco %
0.00
0.00
LAXMIDENTL
PE Ratio
56.40
56.40
1Y Return
44.06%
44.06%
Buy Reco %
100.00
100.00
TARSONS Sentiment Analysis
TARSONS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
TARSONS Stock Summary · August 2026
Management described a quarter of strong top-line recovery alongside near-term margin and profitability pressure as the company moved through a major capacity build-out. Consolidated revenue rose almost 21% year over year to Rs. 110 crore in Q1 FY27, while standalone revenue increased 21% to Rs. 86 crore, both helped by broad domestic traction and a 29% rebound in exports as overseas order conversions improved. Management said growth still came mainly from the existing portfolio, with the new facilities and products contributing little so far. The tone was confident but measured: the business was presented as resilient, the German subsidiary showed about 6% constant-currency growth, and Panchla’s ramp-up was already supporting revenue from existing products and shifted capacity. At the same time, gross margin softened to 67.1% and EBITDA was pressured by raw material inflation, commissioning costs, depreciation, and interest. Management said more of the capex program will be commissioned in Q2, with benefits becoming clearer from FY28, while FY27 profit is expected to stay relatively moderate and growth of about 15% appears achievable, with further upside dependent on new products.
TARSONS Stock Growth Drivers
TARSONS Stock Growth Drivers
8Strong Core Revenue Momentum
The company delivered a strong start to FY27 with broad-based top-line growth, supported primarily by
Export Rebound and International Growth Opportunity
The overseas business showed a clear recovery, with India export revenue rebounding sharply and rising
TARSONS Stock Challenges
TARSONS Stock Challenges
7Input-cost inflation and margin compression
Profitability has been hit by a sharp rise in raw material and polymer costs, with
Profitability remains subdued during capex ramp-up
Recent commissioning of new facilities has increased depreciation and interest expense, weighing on quarterly profit
TARSONS Forecast
TARSONS Forecasts
Price
Revenue
Earnings
TARSONS Share Price Forecast
TARSONS Share Price Forecast
2026
Current
₹304.15
Baseline
Forecast for Apr 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹304.15
Baseline
Forecast for Apr 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TARSONS Company Revenue Forecast
TARSONS Company Revenue Forecast
2026
Current
₹446.68
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2026
Current
₹446.68
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
TARSONS Stock EPS (Earnings Per Share) Forecast
TARSONS Stock EPS (Earnings Per Share) Forecast
2026
Current
₹2.69
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹2.69
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TARSONS
TARSONS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
TARSONS Income Statement
TARSONS Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 109.10 | 87.70 | 107.67 | 96.53 | 116.47 | 94.70 | 108.13 | 116.32 | 127.76 | 116.22 | ||||||||||
Operating & Other expenses | 75.47 | 66.04 | 73.94 | 66.04 | 75.67 | 66.66 | 74.89 | 77.73 | 86.66 | 84.26 | ||||||||||
EBITDA | 33.63 | 21.66 | 33.73 | 30.49 | 40.80 | 28.04 | 33.24 | 38.59 | 41.10 | 31.96 | ||||||||||
| Depreciation/Amortization | 12.33 | 11.03 | 14.03 | 17.41 | 20.03 | 19.94 | 22.48 | 25.04 | 29.08 | 27.02 | ||||||||||
| PBIT | 21.30 | 10.63 | 19.70 | 13.08 | 20.77 | 8.10 | 10.76 | 13.55 | 12.02 | 4.94 | ||||||||||
| Interest & Other Items | 4.25 | 4.32 | 4.84 | 5.03 | 5.20 | 5.07 | 5.18 | 6.05 | 6.25 | 6.27 | ||||||||||
| PBT | 17.05 | 6.31 | 14.86 | 8.05 | 15.57 | 3.03 | 5.58 | 7.50 | 5.77 | -1.33 | ||||||||||
| Taxes & Other Items | 6.73 | 2.30 | 4.58 | 2.79 | 5.37 | 1.25 | 2.27 | 2.47 | 1.59 | 0.12 | ||||||||||
| Net Income | 10.32 | 4.01 | 10.28 | 5.26 | 10.20 | 1.78 | 3.31 | 5.03 | 4.18 | -1.45 | ||||||||||
| EPS | 1.94 | 0.75 | 1.93 | 0.99 | 1.92 | 0.34 | 0.62 | 0.95 | 0.79 | -0.27 |
TARSONS Company Updates
FY 2027FY 2027
Investor Presentation
Aug 10PDF
TARSONS Stock Peers
TARSONS Past Performance & Peer Comparison
TARSONS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Tarsons Products Ltd | 114.44 | 2.58 | — |
| Inventurus Knowledge Solutions Ltd | 40.20 | 10.36 | — |
| Poly Medicure Limited | 53.89 | 5.51 | 0.20% |
| Molbio Diagnostics Limited | 88.91 | 11.32 | — |
TARSONS Stock Price Comparison
Compare TARSONS with any stock or ETFCompare TARSONS with any stock or ETF
TARSONS
TARSONS Holdings
TARSONS Shareholdings
TARSONS Promoter Holdings Trend
TARSONS Promoter Holdings Trend
TARSONS Institutional Holdings Trend
TARSONS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TARSONS Shareholding Pattern
TARSONS Shareholding Pattern
TARSONS Shareholding History
TARSONS Shareholding History
Foreign Institutions
Mutual Funds Invested in TARSONS
Mutual Funds Invested in TARSONS
No mutual funds holding trends are available
Top 1 Mutual Funds holding Tarsons Products Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.03% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 113/130 (+4) |
Compare 3-month MF holding change on Screener
smallcases containing TARSONS stock
smallcases containing TARSONS stock
Looks like this stock is not in any smallcase yet.
TARSONS Events
TARSONS Events
TARSONS Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TARSONS Dividend Trend
No dividend trend available
TARSONS Upcoming Dividends
TARSONS Upcoming Dividends
No upcoming dividends are available
TARSONS Past Dividends
TARSONS Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2024
TARSONS Stock News & Opinions
TARSONS Stock News & Opinions
Articles & Videos
Corporate
Corporate
Tarsons Products to review quarterly financial results at board meeting on August 10Tarsons Products Limited will hold a board meeting on August 10, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The trading window for the company's designated persons and their immediate relatives will remain closed for 48 hours following the declaration of the financial results, as previously intimated on June 23, 2026.
1 month agoCapital Market - Live
Earnings
Earnings
Tarsons Products consolidated net profit declines 59.02% in the March 2026 quarterNet profit of Tarsons Products declined 59.02% to Rs 4.18 crore in the quarter ended March 2026 as against Rs 10.20 crore during the previous quarter ended March 2025. Sales rose 7.31% to Rs 120.93 crore in the quarter ended March 2026 as against Rs 112.69 crore during the previous quarter ended March 2025. For the full year,net profit declined 51.90% to Rs 14.32 crore in the year ended March 2026 as against Rs 29.77 crore during the previous year ended March 2025. Sales rose 7.67% to Rs 422.51 crore in the year ended March 2026 as against Rs 392.41 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales120.93112.69 7 422.51392.41 8 OPM %28.3432.85 -27.9128.22 - PBDT34.6335.60 -3 119.56107.30 11 PBT5.5515.57 -64 23.0344.80 -49 NP4.1810.20 -59 14.3229.77 -52 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Tarsons Products schedules board meetingTarsons Products will hold a meeting of the Board of Directors of the Company on 22 May 2026.
4 months agoCapital Market - Live
Corporate
Corporate
Board of Tarsons Products approves investment of EUR 3 million in Tarsons Life ScienceThe board of Tarsons Products at its meeting held on 06 February 2026 has approved equity infusion of further EUR 3 Million in its wholly-owned subsidiary, Tarsons Life Science, a company incorporated in Singapore for meeting its operational and financial expenses.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Board of Tarsons Products approves change in directorateThe board of Tarsons Products at its meeting held on 06 February 2026 has approved the appointment of Vinesh Mohan Kriplani (DIN: 08212644) as an Additional Director (Category: Non-Executive Independent Director). The board also accepted the resignation of Girish Paman Vanvari (DIN:07376482) as an Independent Director of the Company. Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Tarsons Products consolidated net profit declines 4.18% in the December 2025 quarterNet profit of Tarsons Products declined 4.18% to Rs 5.04 crore in the quarter ended December 2025 as against Rs 5.26 crore during the previous quarter ended December 2024. Sales rose 12.76% to Rs 107.89 crore in the quarter ended December 2025 as against Rs 95.68 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales107.8995.68 13 OPM %29.2130.97 - PBDT33.8925.46 33 PBT8.868.05 10 NP5.045.26 -4 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Tarsons Products to conduct board meetingTarsons Products will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Tarsons Products consolidated net profit declines 67.74% in the September 2025 quarterNet profit of Tarsons Products declined 67.74% to Rs 3.32 crore in the quarter ended September 2025 as against Rs 10.29 crore during the previous quarter ended September 2024. Sales rose 3.10% to Rs 102.33 crore in the quarter ended September 2025 as against Rs 99.25 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales102.3399.25 3 OPM %26.8225.49 - PBDT28.0728.90 -3 PBT5.5914.87 -62 NP3.3210.29 -68 Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
Earnings
Tarsons Products standalone net profit declines 49.50% in the September 2025 quarterNet profit of Tarsons Products declined 49.50% to Rs 6.53 crore in the quarter ended September 2025 as against Rs 12.93 crore during the previous quarter ended September 2024. Sales rose 0.49% to Rs 80.51 crore in the quarter ended September 2025 as against Rs 80.12 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales80.5180.12 0 OPM %32.4729.34 - PBDT29.0529.48 -1 PBT8.8817.52 -49 NP6.5312.93 -49 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Tarsons Products announces board meeting dateTarsons Products will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant